Retour
24
25
46
43
34
Fourchette du Jour
224,92 €
231,45 €
Fourchette 52 Semaines
199,92 €
293,81 €
Volume
1 000 692
Moyenne 50J / 200J
252,88 €
/
260,16 €
Clôture Précédente
227,97 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,8 | 0,3 |
| P/B | 5,6 | 2,9 |
| ROE % | 25,9 | 3,7 |
| Net Margin % | 27,2 | 3,8 |
| Rev Growth 5Y % | 12,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
295,88 €
+29.7%
Low: 265,00 €
High: 345,00 €
P/E Prévisionnel
20,6
BPA Prévisionnel
11,05 €
Croissance BPA (est.)
+0,0%
CA Est.
5,6 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
16,20 €
15,91 € – 16,44 €
|
7,8 B | 4 |
| FY2029 |
14,38 €
14,13 € – 14,59 €
|
7 B | 3 |
| FY2028 |
13,43 €
12,12 € – 14,29 €
|
6,5 B | 9 |
Points Clés
Revenue grew 12,64% annually over 5 years — strong growth
Earnings grew 37,20% over the past year
ROE of 25,86% indicates high profitability
Net margin of 27,22% shows strong profitability
Debt/Equity of 0,14 — conservative balance sheet
Generating 1,66B in free cash flow
Croissance
Revenue Growth (5Y)
12,64%
Revenue (1Y)9,84%
Earnings (1Y)37,20%
FCF Growth (3Y)72,37%
Qualité
Return on Equity
25,86%
ROIC18,53%
Net Margin27,22%
Op. Margin32,75%
Sécurité
Debt / Equity
0,14
Current Ratio3,44
Interest Coverage133,66
Valorisation
P/E Ratio
23,78
P/B Ratio5,58
EV/EBITDA19,55
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,84% | Revenue Growth (3Y) | 10,39% |
| Earnings Growth (1Y) | 37,20% | Earnings Growth (3Y) | 24,92% |
| Revenue Growth (5Y) | 12,64% | Earnings Growth (5Y) | 31,08% |
| Profitability | |||
| Revenue (TTM) | 5,15B | Net Income (TTM) | 1,40B |
| ROE | 25,86% | ROA | 17,14% |
| Gross Margin | 59,36% | Operating Margin | 32,75% |
| Net Margin | 27,22% | Free Cash Flow (TTM) | 1,66B |
| ROIC | 18,53% | FCF Growth (3Y) | 72,37% |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 3,44 |
| Interest Coverage | 133,66 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 23,78 | P/B Ratio | 5,58 |
| P/S Ratio | 6,47 | PEG Ratio | 0,72 |
| EV/EBITDA | 19,55 | Dividend Yield | 0,01% |
| Market Cap | 33,31B | Enterprise Value | 32,95B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,15B | 4,69B | 4,22B | 3,58B | 3,20B |
| Net Income | 1,40B | 1,02B | 897,56M | 779,44M | 474,51M |
| EPS (Diluted) | 9,51 | 6,92 | 6,09 | 5,30 | 3,24 |
| Gross Profit | 3,05B | 2,66B | 2,36B | 2,02B | 1,84B |
| Operating Income | 1,69B | 1,32B | 1,13B | 1,00B | 903,68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,17B | 6,87B | 6,75B | 5,10B | 4,73B |
| Total Liabilities | 2,21B | 2,01B | 2,62B | 1,74B | 1,84B |
| Shareholders' Equity | 5,97B | 4,86B | 4,13B | 3,36B | 2,89B |
| Total Debt | 851,81M | 873,94M | 1,58B | 917,55M | 793,72M |
| Cash & Equivalents | 1,21B | 238,36M | 227,89M | 273,71M | 295,28M |
| Current Assets | 3,51B | 2,36B | 2,37B | 1,93B | 1,57B |
| Current Liabilities | 1,02B | 910,66M | 758,53M | 689,30M | 911,77M |
Scores de Stratégies
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#932 of 1052
Custom
Capital Light Compounder
#187 of 218
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#203 of 332
Custom
Balanced Risk
#94 of 151
Custom
Lower Risk
#120 of 140
Activité Récente
Entré
Cash Flow Compounder
Mar 25, 2026
Entré
Capital Light Compounder
Mar 25, 2026
Entré
Balanced Risk
Mar 25, 2026
Entré
Lower Risk
Mar 25, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026